Back
Revvity, Inc. (RVTY)
Life Sciences Tools & ServicesRVTY · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$112.26
−0.63%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$2.07
ROE
3.2%
Gross margin
54.3%
Debt/Equity
0.47x
Revenue growth
7.0%
Revvity, Inc. — company intelligence
Earnings surprises
Q1 2026$1.06 vs $1.04 est+2.3%
Q4 2025$1.70 vs $1.58 est+7.4%
Q3 2025$1.18 vs $1.16 est+1.7%
Q2 2025$1.18 vs $1.16 est+1.5%
Insider activity · 90 days
18 buys1 sellnet +20,844 shares
Witz PascaleBuy 1,265 · May 7, 2026
Barrett PeterBuy 1,265 · May 7, 2026
Chapin Samuel R.Buy 1,015 · May 7, 2026
Recent SEC filings
4 — Insider transaction reportJun 17, 2026
10-Q — Quarterly reportMay 12, 2026
4 — Insider transaction reportMay 11, 2026
Latest news
Evercore ISI Group Maintains Outperform on Revvity, Raises Price Target to $125 — Benzinga · 4d ago
What You Need to Know Ahead of Revvity’s Earnings Release — Yahoo · 1w ago
3 Reasons to Avoid RVTY and 1 Stock to Buy Instead — Yahoo · 1w ago
Revvity Expands Signals AI With Anthropic Claude Integration — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Revvity, Inc.
Weekly undervalued picks (like RVTY)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.